Strategic Analysis of Gel Column Agglutination Test System Market Industry Opportunities
The Gel Column Agglutination Test System market is booming, with a projected CAGR of 5.50% from 2025-2033. Driven by rising infectious disease prevalence and demand for rapid diagnostics, this market offers significant opportunities across pharmaceuticals, blood banks, and diagnostic centers. Learn about market trends, key players (Bio-Rad, QIAGEN, etc.), and regional growth projections.